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Abstract
Background: The malaria aldolase is widely used as rapid diagnostic test (RDT), but the efficacy in aspect of its
serological effectiveness in diagnosis is not known. The genetic variation of Korean isolates was analysed and
recombinant aldolase was evaluated as a serological antigen in Plasmodium vivax malaria.
Methods: Genomic DNA was purified and the aldolase gene of P. vivax from 25 patients’ blood samples was
amplified. The samples came from 5 epidemic areas; Bucheon-si, Gimpo-si, Paju-si of Gyeonggido, Gangwha-gun of
Incheon metropolitan city, and Cheorwon of Gangwon-do, South Korea. The antigenicity of the recombinant
aldolase was tested by western blot and enzyme-linked immunosorbent assay (ELISA).
Results: Sequence analysis of 25 Korean isolates of P. vivax showed that the open reading frame (ORF) of 1,110
nucleotides encoded a deduced protein of 369 amino acids (aa). This ORF showed 100% homology with the
P. vivax Sal I strain (XM_00165894) and P. vivax WDK strain (AF247063), 87.4% homology with Plasmodium falciparum
(AF179421), 90.6% homology with Plasmodium chabaudi (AF247060), 89.5% homology with Plasmodium vinckei
(AF247061), and 96.7% homology with Plasmodium knowlesi. A single nucleotide polymorphism (SNP) at nucleotide
180 (G to A, n=5) was also observed in the isolates. The expressed recombinant protein had a molecular weight of
approximately 31 kDa (monomeric form) and 62 kDa (dimeric form) as analysed by sodium dodecyl sulfate-
polyacrylamide gel electrophoresis (SDS-PAGE) analysis. Among 109 P. vivax patients, 32 (29.4%) had positive in an
enzyme-linked absorbance assay (ELISA). This result showed significant correlation between ELISA and an indirect
fluorescent antibody test (IFAT) (P<0.0001).
Conclusions: The aldolase gene from Korean isolates of P. vivax showed one SNP at nucleotide position 180; this
SNP mutant was discovered in only the western part of Han River, and included the regions of Ganghwa, Gimpo,
and Bucheon. Based on the results, the relationship between antibody production against aldolase and the pattern
of disease onset should be more investigated before using aldolase for serodiagnosis.
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Microscopic examination of the Plasmodium species is
regarded as the gold standard method for malaria diagnosis.
Despite the simplicity and low cost, it is not always available
[1]. Over the last ten years, the development of alternative
diagnostic tests for malaria, such as rapid diagnostic tests
(RDTs), has made it possible to extend biological diagnosis to
remote areas with few resources. These lateral-flow immuno-
chromatographic tests detect specific antigens produced by
malaria parasites and are rapid and simple to carry out with-
out electricity, specific equipment or intensive training [2-4].
To detect Plasmodium, monoclonal antibodies against
lactate dehydrogenase (pLDH), histidine-rich protein-2
(HRP-2) and aldolase are widely used [5,6]. The genetic
diversity of HRPII is known to partly influence the sensi-
tivity of RDT [7]. It is known that the genetic variation
of aldolase genes is very low [8,9], but it is not clear if
this is true in the Korean isolates of Plasmodium vivax.
Aldolase is a key enzyme that helps convert glucose into
energy in malaria parasites. Meier et al found that two
type of aldolase, aldo-1 and aldo-2, from Plasmodium
berghei. aldo-1 of P. berghei was found to be virtually
identical to the aldolase gene of Plasmodium falciparum,
whereas aldo-2 had 13% sequence diversity. In addition,
aldo-1 was detected in the sporozoite stage while aldo-2
was detected in the asexual stages of malaria parasites
with specific antibody probes [10].
In this study, it was investigated that genetic variation
of aldolase genes which were isolated from 25 patients
who lived in 5 geographically different epidemic areas in
South Korea and evaluated the recombinant protein as a
serodiagnostic tool.
Methods
Blood sample collection
Patients with clinically suspected malaria attending the Pub-
lic Health Centres in Gangwha-gun, Gimpo-si, Bucheon-si,
Paju-si of Gyeonggi-do and Cheorwon-gun of Gangwon-do,
South Korea in 2011, were examined for malaria parasites.
Approximately 3 ml of blood was collected from each
symptomatic patient. Thin and thick blood smears were
prepared for microscopic examination (magnification
7×100). Blood samples were transported to the Korean
N a t i o n a lI n s t i t u t eo fH e a l t h( K N I H ) ,w h e r es e r aw e r e
separated and stored at −20°C for future antibody ana-
lysis. Informed consent was obtained from all patients,
and all samples were collected under human use protocols
that have been reviewed and approved by the Human
Ethics Committee of the National Institute of Health
(Osong, Korea).
Amplification of the aldolase gene
For the purpose of expression of the aldolase gene, genomic
DNA was extracted from the whole blood of a malaria
patient using a QIAamp Blood Kit (Qiagen, Hilden,
Germany). PCRs were performed using AccuPower PCR
Premix (Bioneer, Taejeon, Korea), 50 ng of purified gen-
omic DNA, 40 pmoles each of forward (AF1; 5′-G C C
ACT GGA TCC GAA TAT AAA AAC GCC CCC-3′)a n d
reverse primers (AR1; 5′- ATA GAC GTA CTT CTT
TTC GTA AAG GGA TGC-3′) and the total volume was
adjusted to 20 ml with distilled water. The thermocycler
conditions were as follows: denaturation at 94°C for 5 min,
35 cycles of 1 min at 94°C, 1 min at 55°C and 2 min at
72°C, and finally incubation at 72°C for 5 min. All of
the PCR products were analysed on a 1.2% agarose gel,
confirmed under a UV transilluminator and purified
with a NucleoSpin Extract Kit (Macherey-Nagel, Duren,
Germany). The purified PCR products were ligated with
pCR2.1 cloning vector (Invitrogen, Carlsbad, CA, USA)
and then transformed into Escherichia coli INVα F’
according to the procedures of Invitrogen.
DNA sequencing and analysis
The PCR product inserted into E. coli was selected for
on ampicillin and X-gal containing medium. To confirm
the transformants, gel electrophoresis was performed with
EcoRI digestion products after preparation of the plasmid
with a Qiagen plasmid isolation kit, according to the
protocol supplied by the manufacturer. The aldolase
gene sequence was determined using ABI PRISM dye
terminator cycle sequencing ready reaction kit FS (Perkin
Elmer, Cambridge, MA, USA) according to the supplied
manual. M13 reverse and M13 forward (−20) primers were
used in sequencing. Nucleotide and deduced amino acid
sequences were analysed using EditSeq and Clustal in the
Megalign program, a multiple alignment program in the
DNASTAR package (DNASTAR, Madison, WI, USA). The
internet-based BLAST search program of the National
Centre for Biotechnology Information (NCBI) was used to
search protein databases. The gene sequences of aldolase
from the Korean isolates were deposited in GenBank
(Accession No. JN181172-JN181196).
Construction of the aldolase expression vector
For the expression of aldolase gene of Pv Kor12 type
strain in E. coli, the gene fragment was amplified from
the DNA of blood samples that were confirmed to be
infected with P. vivax as described above, and which
have the SmaI and SalI sites on their 5′ ends. Amplified
PCR products were digested with SmaI and SalI, purified
with a Qiagen Gel Extraction Kit after being run on an
agarose gel and were then integrated into the SmaI
and SalI cleavage sites of the pQE80 expression vector
(Qiagen). The resulting plasmid was subsequently used
for the expression of the aldolase fusion protein in
E. coli DH5a [11]. Transformants were confirmed both
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enzyme digestion with SmaIa n dSalI.
Expression and purification of recombinant aldolase
Expression of the recombinant protein was induced in
E. coli with isopropyl-1-thio-β-D-galactopyranoside (IPTG)
[12]. 1 mM IPTG was added to cultures of E. coli DH5α
(pVKor12) grown to a logarithmic phase in liquid LB con-
taining 100 μg/ml ampicillin and 25 μg/ml kanamycin to
induce expression of the target protein and purification of
the aldolase fusion protein was carried out using immobi-
lized metal ion affinity chromatography [13]. The purifica-
tion was done under native conditions according to the
supplier’s protocol (Qiagen). Proteins were analyzed on so-
dium dodecyl sulfate-polyacrylamide gel electrophoresis
(SDS-PAGE) in each purification step.
Western blot analysis
Recombinant aldolase fusion protein was separated on a
12% SDS-PAGE gel and was then transferred to a nitro-
cellulose membrane. After the transfer, the membrane
was cut into strips and blocked for non-specific binding
with 5% skim milk for 12 hrs at 4°C. The membrane was
then washed in PBS with 0.15% Tween 20 for 3×10 min.
The strips were allowed to react with sera of malaria
patients or of uninfected people (diluted 1:100, vol/vol)
for 4 hrs and then washed using the procedure described
above. The membrane was then incubated with diluted
peroxidase-conjugated goat anti-human IgG secondary
antibody (1:1,000, v/v) (Sigma) for 3 hrs at room temper-
ature. For colour development, a solution containing 0.2%
diaminobenzidine and 0.02% H2O2/PBS was applied to each
well [14,15].
Enzyme-linked immunosorbent assay
Sera from patients infected with P. vivax were analysed for
the presence of antigen-specific antibody using 96-well
plates coated with 0.5 mg/ml purified recombinant pro-
tein that had been expressed in E. coli and dissolved in
phosphate-buffered saline (PBS, pH 7.4) overnight at 4°C.
Malaria patient serum was diluted 1:100 (v/v) in blocking
buffer (0.25% PBS-Tween 20 with 1% bovine serum albu-
min, pH 7.4) and incubated for 1 hr, followed by incuba-
tion with peroxidase-conjugated goat anti-human IgG
secondary antibody at a 1:1,000 dilution (v/v, Sigma).
Optical density was measured with a spectrophotometer
at 405 nm (Molecular Devices, Sunnyvale, CA) [15]. It
was regarded as positive sera showed over the cut off
value which obtained by mean±2 X standard deviation
(SD) of negative controls.
Indirect fluorescent antibody test
To test for antibodies against malaria, indirect fluores-
cent antibody test (IFAT) was performed using the whole
blood antigen for P. vivax [16-18]. Briefly, 10 ml of malaria
parasite-infected blood was collected by venopuncture
from P. vivax patients. After plasma removal, the blood
cells were suspended in phosphate buffered saline (PBS,
pH 7.2) and centrifuged for 5 min at 2,500 rpm. The
supernatant was discarded and the cells were resuspended
in fresh PBS. This wash step was repeated three more
times, and then an appropriate amount of PBS was added
to maintain the parasitaemia at no less than 1%. Cells were
added to each well contained in Teflon coated slides. After
12 hrs drying at room temperature, the slides were stored
at −70°C. In order to determine the antibody titres against
P. vivax for each patient, the antigen slides were fixed in
pre-cooled acetone (−20°C) for 10 min, washed with PBS,
and then 20 μl of diluted sera, 1:32 to 1:8,192 (vol/vol),
was added to each well. Positive and negative controls
were also spotted onto each slide and then the slide was
incubated in a humidified chamber for 30 min at 37°C.
The reactions on the slides were quenched by washing the
reacted sera with PBS for 6 min, and then the slides were
dried at room temperature. Diluted FITC conjugated anti-
human IgG (Sigma, 1:32 vol/vol in PBS) was added to each
well and then the slides were incubated and washed using
the same method described above. Several drops of buf-
fered glycerol were added to the samples, and then cover-
slips were applied. The slides were examined under the
40x objective of a fluorescence microscope.
Data analysis
The relationship between ELISA and IFAT positive rate
was analyzed by one-way ANOVA. Data analyses were
performed using GraphPad (GraphPad Software, Inc.,
La Jolla, CA, USA).
Results
Blood collection and sequence variation of aldolase from
Korean isolates of Plasmodium vivax
The geographical locations of study areas were expressed
in Figure 1. Gangwha-gun, Gimpo-si, and Bucheon-si are
located along the western part of Han River, which is the
largest river that passes through Seoul, South Korea.
Paju-si and Cheorwon-gun are located along the eastern
part of Han River. Five blood samples infected with indi-
genous P. vivax were collected from each city in 2011.
Among 25 Korean isolates of aldolase, 12 isolates had the
same DNA and amino acid sequences as P. vivax Sal-1
(XM_001615894) and these were designated as strain type
Pv Kor12. The aldolase from these isolates had 1110
nucleotides and 386 amino acids. When the amino acid of
Pv Kor12 was compared with several Plasmodium species,
Pv Kor12 showed 100% homology with P. vivax WDK
(AF247063, 1110 bp), 87.4% homology with P. falciparum
(AF179421, 1089 bp), 90.6% homology with P. chabaudi
(AF247060, 1054 bp), 89.5% homology with P. vinckei
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(XM_002260389, 1170 bp) (Figures 2 and 3).
The aldolase gene was amplified from the genomic
DNA of 25 Korean isolates. Amplification of the aldolase
gene yielded a product of approximately 1,100 base pairs.
After purification, the DNA fragment was ligated into
the pCR 2.1 cloning vector (3.9 kb). The plasmid con-
taining the PCR product was named pValdol (5.0 kb) and
was used for DNA sequence analysis. Based on DNA se-
quencing, the cloned aldolase gene was shown to be
1,110 bp and consisted of 386 amino acids that were
deduced by DNASIS. One synonymous single nucleotide
polymorphism (SNP) at base pair 180 (n=5), from G to A,
was observed based on literatures [6,8]. Two of SNP
were from Gangwha-gun, one from Gimpo-si, two from
Bucheon-si, and none were from Paju-si or Cheorwon-gun
(Figure 4). Rest of them (n=8) has one or two SNPs, but
those locations did not show any common feature. These
should be cleared through the analysis of the more DNA
samples.
Expression of aldolase in E. coli
The resultant plasmid pVKor12 contained the aldolase
gene fused to a (His)6-tag (Figure 5A). The recombinant
plasmid pVKor12 was then transferred into E. coli DH5α.
As analysed on SDS-PAGE followed by Coomasie blue
staining, two forms of recombinant aldolase protein were
observed under native purification conditions, a dimeric
form (62 kDa) and a monomeric form (31 kDa) (Figure 5B).
M----------------------------------NAPLKLPAEVAEEIATTAKKLVEAGKGILAADESTQTIKKRFDNINVENTIENRASYRDLLFGTK Majority
10 20 30 40 50 60 70 80 90 100
.ATGSEYK---------------------------................................................................. 7 3 Pv Sal-1
.ATGSEYK---------------------------................................................................. 7 3 Pv Kor12
.ATGSEYK---------------------------................................................................. 7 3 WDK
.----------------------------------...K....D....L....QE..Q......................KL.................. 6 6 P.falciparum
.--------------------------------------...K...H.L.E......AP.....................KI...V....N......... 6 2 P.chabaudi
.--------------------------------------...K...Q.L.D......AP.....................KID..V.............. 6 2 P.vinckei
.-------SAPYPRMVIPFSCQNSCDVYATVSEYK........D.............Q...........................V....A......... 9 3 P.knowlesi
GLGKFISGAILFEETLFQKNEAGVPLVNLLHDEGIIPGIKVDKGLVTIPCTDDEKSTQGLDGLAERCKEYYKAGARFAKWRAVLVIDPVKGKPTDLSIQE Majority
110 120 130 140 150 160 170 180 190 200
....................................................................................................  173 Pv Sal-1
.................................................................................................... 1 7 3 Pv Kor12
.................................................................................................... 1 7 3 WDK
.........................M.....N.N............N.....E.E........S............S.I..T.....TA.RN......H. 1 6 6 P.falciparum
.................................D............S...................................................H.  162 P.chabaudi
................................QN............A.........................................A...........  162 P.vinckei
....................................................................................................  193 P.knowlesi
TAWGLARYASICQQNKLVPIVEPEILADGSHTIEVCATVTQKVLASVFKALHDQGVLLEGALLKPNMVTAGYDCAVKTNTQDIGFLTVRTLSRTVPPALP Majority
210 220 230 240 250 260 270 280 290 300
.................................................................................................S.. 2 7 3 Pv Sal-1
.................................................................................................S..  273 Pv Kor12
.................................................................................................S..  273 WDK
...............R.............P.S.....V......SC.....QEN...........D...G..E.TA..T...V........R........  266 P.falciparum
VS.......A...................G.......................N....................TE..K.D....F.....R........  262 P.chabaudi
VS.......A...................A.......A...............N....................PE..K.E....F..............  262 P.vinckei
.............................................C.........I..................T...K..................... 2 9 3 P.knowlesi
GVVFLSGGQSEEEASVNLNSINALGPHPWALTFSYGRALQASVLNTWKGKKENVAKAREVLLKRAEANSLATYGKYKGGAGGADAGASLYEKKYVYX Majority
310 320 330 340 350 360 370 380 390
370 Pv Sal-1
370 Pv Kor12
......................................................E.........................................      369 WDK
363 P.falciparum
............D.........V.....................S..Q..............Q...................ST.....             3 5 1 P.chabaudi
............D.......M.V.....................S..Q.....A...Q....Q...................ST.....             3 5 1 P.vinckei
390 P.knowlesi
Figure 2 Multiple amino acid sequence alignment. The deduced amino acid sequence of Pv Kor12 type strain in Korean isolates of P. vivax
was aligned with those from other Plasmodium species. Computer analysis was performed using the multiple sequences alignment of MegAlign.
All amino acid sequences were obtained from GenBank BLAST (http://WWW.ncbi.nlm.nih.gov). P. vinckei (Accession; AF247061), P. chabaudi
(AF247060), WDK; P. vivax WDK (AF247063), Pv Kor12; type strain from P. vivax Korean isolate, Pv Sal-1; Sal-1 strain of P. vivax (XM_00165894),
P. falciparum (AF179421), and P. knowlesi (XM_002260389).
A
C
D
E
DMZ
South Korea
North Korea
Yellow Sea
B
Figure 1 Studied areas. A; Ganghwa-gun, B; Gimpo-si, C; Bucheon-si,
D; Paju-si, E; Cheorwon-gun. DMZ; demilitarized zone.
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To determine the antigenicity of the aldolase recombinant
protein by western blot, ELISA, and IFAT, sera of malaria
patients which had been reserved in KNIH collected be-
tween 2009 and 2010. Negative sera were collected from
volunteers of stuffs in KNIH. Sera of twelve malaria
patients showed positive reaction by western blot while
the sera from the normal control group (n=7), who had
never been exposed to malaria, tested negative (Figure 6).
After the number of malaria patients was increased, the
antigenicity of recombinant aldolase was evaluated by
ELISA. Thirty-two of 109 sera (29.4%) from malaria patients,
as confirmed by microscopic analysis, reacted with the
aldolase recombinant antigen. In addition, 3 of 67 normal
persons (4.5%) reacted with the aldolase recombinant anti-
gen (Figure 7). The reaction intensity of the recombinant
aldolase antigen with patient sera increased significantly
depends on the positive reactions of each serum dilution
Nucleotide Substitutions (x100)
0
131.0
20 40 60 80 100 120
P.vinckei
P.chabaudi
WDK
Pv Kor12
Pv Sal-1
P.falciparum
P.knowlesi
Figure 3 Phylogenetic relationships between the aldolase genes of several strains of Plasmodium. Computer analysis was performed using
the multiple sequences alignment of MegAlign. All amino acid sequences were obtained from GenBank BLAST (http://WWW.ncbi.nlm.nih.gov).
P. vinckei (Accession; AF247061), P. chabaudi (AF247060), WDK; P. vivax WDK (AF247063), Pv Kor12; Type strain of from P. vivax Korean isolate, Pv
Sal-1; Sal-1 strain of P. vivax (XM_00165894), P. falciparum (AF179421), and P. knowlesi (XM_002260389).
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Bucheon-1
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Bucheon-3
Bucheon-4
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Paju-1
Paju-2
Paju-3
Paju-4
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Cheorwon-1
Cheorwon-2
Cheorwon-3
ACACCATCGAGAACAGAGCTAGCTA
ACACCATCGAGAACAGAGCTAGCTA
ACACCATCGAAAACAGAGCTAGCTA
ACACCATCGAGAACAGAGCTAGCTA
ACACCATCGAAAACAGAGCTAGCTA
ACACCATCGAGAACAGAGCTAGCTA
ACACCATCGAGAACAGAGCTAGCTA
ACACCATCGAGAACAGAGCTAGCTA
ACACCATCGAGAACAGAGCTAGCTA
ACACCATCGAAAACAGAGCTAGCTA
ACACCATCGAAAACAGAGCTAGCTA
ACACCATCGAAAACAGAGCTAGCTA
ACACCATCGAGAACAGAGCTAGCTA
ACACCATCGAGAACAGAGCTAGCTA
ACACCATCGAGAACAGAGCTAGCTA
ACACCATCGAGAACAGAGCTAGCTA
ACACCATCGAGAACAGAGCTAGCTA
ACACCATCGAGAACAGAGCTAGCTA
ACACCATCGAGAACAGAGCTAGCTA
ACACCATCGAGAACAGAGCTAGCTA
ACACCATCGAGAACAGAGCTAGCTA
ACACCATCGAGAACAGAGCTAGCTA
ACACCATCGAGAACAGAGCTAGCTA
ACACCATCGAGAACAGAGCTAGCTA Cheorwon-4
A C A CCA TCG A G A A C A GAG CTA GCTA Cheorwon-5
170                                       180                                          190 Nucleotide
*
*
*
*
*
*
*
*
*
*
*
*
Figure 4 Comparing the single nucleotide polymorphism (SNP) of the aldolase gene between 25 Plasdodium vivax Korean isolates.
*; represents the isolate belong to PvKor12. All amino acid sequences were deposited in GenBank BLAST (http://WWW.ncbi.nlm.nih.gov,
Accession No. JN181172-JN181196).
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reached a maximum level at a 1:512 serum dilution of
IFAT.
Discussion
Aldolase is an important enzyme involved in the glycoly-
sis pathway of malaria parasites. Higher vertebrates usu-
ally has three kind of tissue-specific aldolase isoenzymes
[19], however, P. falciparum and P. vivax posses only
one aldolase isoenzyme [20,21], similar to Trypanosoma
brucei [22]. The aldolase enzymes of P. falciparum and
P. vivax are both 369 amino acids long and their nucleo-
tide and amino acid sequences are relatively conserved
than other genes’ variation [21]. However, genetic variation
of the aldolase gene of Korean isolates is not analysed sys-
tematically. Therefore, it is important to understand the
genetic variation of the aldolase gene in Korean isolates.
For the 110 P. vivax aldolase gene sequences from
Madagascar isolates, only two synonymous changes were
observed. A SNP at nucleotide 510 (TCC to TCA) was
found in one isolate from the Tsiroanomandidy area,
whereas an SNP at nucleotide 651 TTA to TTG) was
observed in 43 isolates from the other regions [23]. Re-
cently, two synonymous SNPs were found among 84
Korean isolates, four cases has changed nucleotide from
G to A at base pair 180, two cases has the same nucleo-
tide change at base pair 645 [6]. However, only one kind
of synonymous SNP was found at base pair 180 (n=5)
in 25 Korean isolates. SNP at base pair 645 has not been
found in this study. It may caused by sample number
used in this study. Together with Cho et al [6] and ours
data, SNP at base pair 180 is dominant mutation than
SNP at base pair 645 in South Korea. Interestingly, mu-
tant strains were isolated from the western part of Han
River, which has an approximate length of 514 Km.
kDa  M     1      2      3      4 
82
64
49
37
26
19
15
Aldolase (1,110 bp)
RBS 6x His
BamHI SmaI SalI HindIII
t
A
B
Figure 5 Gene structure for the expression of Pv aldolase (A). Patterns of purified aldolase by SDS-PAGE under native conditions using
Ni-NTA agarose resin (B). Lane 1: Crude cell lysate, Lane 2: Flow-through, Lane 3: 20 mM imidazole wash, Lane 4: 250 mM imidazole elution,
Lane M: Protein size marker. RBS: ribosome binding site, 6xHis: 6x Histidine tag sequence, t: stop codon.
B A
Figure 6 Western blot analysis of aldolase recombinant protein. A: Malaria patients, B: Healthy individuals.
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Therefore, the SNP found in the aldolase gene sequence
may be related to the geographical isolation caused by the
river. The flight distance a night of Anopheles sinensis,t h e
main mosquito vector in Korea, is mainly limited to 1 Km
[24], so the river is big enough to prevent mosquitoes
crossing the river directly.
Plasmodium vivax has presumably been prevalent in
Korea for a long time. However, as a result of a national
malaria eradication programme and with help from the
WHO, the incidence of vivax malaria has rapidly decreased
[25,26]. After the latest report of two malaria patients in
1985 [27], there were no additional reported cases until
one case was reported in 1993 [28] and two indigenous
cases were reported in 1994 [29]. Malaria cases then rap-
idly increased until around 2000 [30,31]. After that, the
reported malaria cases were reduced for several years due
to efforts to limit the incidence of malaria. However, mal-
aria was not thoroughly eradicated in the Korean peninsula
because 2–3% of patients experience failed drug treatment
every year, and many travellers and workers come from
malaria-prevalent areas, including North Korea [32]. For
these reasons, serological diagnostic tools are needed to
support both traditional microscopic diagnosis and ser-
oepidemiological studies for estimating the prevalence
of malaria in Korea. Currently, IFAT is used as the gold
standard method due to its high sensitivity. However,
the sensitivity might be affected by the ability of exami-
ners. Therefore, a new technique is needed for serodiag-
nosis. Several recombinant proteins cloned from Korean
isolates of P. vivax were tested for use as the antigen
for serodiagnosis, including circumsporozoite protein
(CSP) –subtypes Pv210 [33] and Pv247 [34], merozoite
surface protein (MSP) [35], as well as CSP and MSP
chimera proteins [36,37]. None of these antigens were
sufficient to replace the IFAT method, because the sen-
sitivity was less than IFAT. Therefore, it was decided to
focus on the enzyme aldolase. Monoclonal antibodies
against aldolase were used in several RDTs and showed
a relatively high sensitivity in detecting malaria para-
sites, including Korean isolates [6].
However, the sensitivity of aldolase was 29.4% (32/109),
even though it was cloned from a type of Korean P. vivax
strain (Pv Kor12, Figure 2). There may be many reasons
and explanations for the low seroconversion rate detected
by ELISA using recombinant aldolase antigen (Figure 7).
The same situation happened for the circumsporozoite
protein (CSP) of P. vivax. The basic reason for the low
seroconversion rate for CSP was linked to a low exposure
of this developmental stage to dendritic cells. When the
seroconversion rate of Korean malaria patients against
CSP antigen was analysed, it was shown to be less than
30%. Therefore, a hypothesis was proposed to explain this
observation. First, this may be explained by the antigeni-
city of CSP or the exposure time of contact between DC
and CSP before entering the liver cells. Second, it may be
explained by the relative short half-life time of CSP anti-
body in relation to onset time of illness after a long
Patient
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Figure 7 Scattergram of absorbances measured by ELISA using
aldolase recombinant protein. Sera from healthy individuals and
malaria patients infected with P. vivax were used. Cut off showed the
mean±2 X SD of negative controls.
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Figure 8 Comparison the values measured by IFAT with whole
blood antigen and the value obtained by ELISA with aldolase
recombinant protein. Significance was evaluated by the one-way
ANOVA. *; P<0.05, ***; P<0.0001.
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matches well the portion of antibody positive rate of CSP
(30%) and the percentage of malaria patients who had a
short incubation period (30%). By analogy, this may
explain the low seroconversion rate of aldolase. This
hypothesis should be tested using blood samples from
long and short incubation period patients, but it is not
easy to identify patients with long and short incubation
periods. Recently, two types of aldolase from P. berghei
were identified. Aldo-1 was identical to the aldolase
gene of P. falciparum and aldo-1 was detected in the
sporozoite stage, while aldo-2 was detected in the asex-
ual stages of malaria parasites [10]. Therefore, it is con-
ceivable that the currently known aldolase of P. vivax
also belongs to the sporozoite stage. This may explain
why recombinant aldolase showed a low seroconversion
in this study. Additionally, if the blood stage-specific iso-
form of aldolase was obtained, it may have much higher
seroconversion rate in ELISA.
Conclusions
The aldolase gene from P. vivax Korea isolates has an SNP
at 180 (G to A) and, interestingly, the mutant strains were
only found along the western part of the Han River. New
information of geographic mapping of aldolase at the
national or regional scale would provide a valuable aid
to developing and updating national anti-malarial policy
guidelines in Korea. Additionally, more information is
needed before using aldolase as a serological diagnostic
antigen.
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